These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29428325)

  • 1. Regional cerebral blood flow predictors of relapse and resilience in substance use recovery: A coordinate-based meta-analysis of human neuroimaging studies.
    Forster SE; Dickey MW; Forman SD
    Drug Alcohol Depend; 2018 Apr; 185():93-105. PubMed ID: 29428325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and Functional Neural Targets of Addiction Treatment in Adolescents and Young Adults: A Systematic Review and Meta-Analysis.
    Hammond CJ; Allick A; Rahman N; Nanavati J
    J Child Adolesc Psychopharmacol; 2019 Aug; 29(7):498-507. PubMed ID: 31313938
    [No Abstract]   [Full Text] [Related]  

  • 3. A preliminary study of longitudinal neuroadaptation associated with recovery from addiction.
    Forster SE; Finn PR; Brown JW
    Drug Alcohol Depend; 2016 Nov; 168():52-60. PubMed ID: 27620345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural Underpinnings of Social Stress in Substance Use Disorders.
    Sahani V; Hurd YL; Bachi K
    Curr Top Behav Neurosci; 2022; 54():483-515. PubMed ID: 34971448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis and review of functional neuroimaging differences underlying adolescent vulnerability to substance use.
    Tervo-Clemmens B; Quach A; Calabro FJ; Foran W; Luna B
    Neuroimage; 2020 Apr; 209():116476. PubMed ID: 31875520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward biomarkers of the addicted human brain: Using neuroimaging to predict relapse and sustained abstinence in substance use disorder.
    Moeller SJ; Paulus MP
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt B):143-154. PubMed ID: 28322982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural responses to negative outcomes predict success in community-based substance use treatment.
    Forster SE; Finn PR; Brown JW
    Addiction; 2017 May; 112(5):884-896. PubMed ID: 28029198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial and neural indicators of resilience among youth with a family history of substance use disorder.
    Martz ME; Zucker RA; Schulenberg JE; Heitzeg MM
    Drug Alcohol Depend; 2018 Apr; 185():198-206. PubMed ID: 29462767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-awareness of problematic drug use: Preliminary validation of a new fMRI task to assess underlying neurocircuitry.
    Moeller SJ; Kundu P; Bachi K; Maloney T; Malaker P; Parvaz MA; Alia-Klein N; London ED; Goldstein RZ
    Drug Alcohol Depend; 2020 Apr; 209():107930. PubMed ID: 32145661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similarities and Differences in Neuroimaging.
    Sun YK; Sun Y; Lin X; Lu L; Shi J
    Adv Exp Med Biol; 2017; 1010():73-89. PubMed ID: 29098669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of functional brain differences predicting relapse in substance use disorder: Actionable targets for new methods of noninvasive brain stimulation.
    Gibson BC; Claus ED; Sanguinetti J; Witkiewitz K; Clark VP
    Neurosci Biobehav Rev; 2022 Oct; 141():104821. PubMed ID: 35970417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualized relapse prediction: Personality measures and striatal and insular activity during reward-processing robustly predict relapse.
    Gowin JL; Ball TM; Wittmann M; Tapert SF; Paulus MP
    Drug Alcohol Depend; 2015 Jul; 152():93-101. PubMed ID: 25977206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Threats to external validity in the neuroprediction of substance use treatment outcomes.
    Gancz NN; Forster SE
    Am J Drug Alcohol Abuse; 2023 Jan; 49(1):5-20. PubMed ID: 36099534
    [No Abstract]   [Full Text] [Related]  

  • 14. Functional neuroimaging for addiction medicine: From mechanisms to practical considerations.
    Ekhtiari H; Faghiri A; Oghabian MA; Paulus MP
    Prog Brain Res; 2016; 224():129-53. PubMed ID: 26822357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging resilience and recovery in alcohol dependence.
    Charlet K; Rosenthal A; Lohoff FW; Heinz A; Beck A
    Addiction; 2018 Oct; 113(10):1933-1950. PubMed ID: 29744956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural correlates of interference resolution in the multi-source interference task: a meta-analysis of functional neuroimaging studies.
    Deng Y; Wang X; Wang Y; Zhou C
    Behav Brain Funct; 2018 Apr; 14(1):8. PubMed ID: 29636070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common and distinct neural targets of treatment: changing brain function in substance addiction.
    Konova AB; Moeller SJ; Goldstein RZ
    Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 2):2806-17. PubMed ID: 24140399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated HF-rTMS Protocol has a Rate-Dependent Effect on dACC Activation in Alcohol-Dependent Patients: An Open-Label Feasibility Study.
    Herremans SC; De Raedt R; Van Schuerbeek P; Marinazzo D; Matthys F; De Mey J; Baeken C
    Alcohol Clin Exp Res; 2016 Jan; 40(1):196-205. PubMed ID: 26727534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional brain recovery in individuals with substance use disorders during abstinence: A review of longitudinal neuroimaging studies.
    Parvaz MA; Rabin RA; Adams F; Goldstein RZ
    Drug Alcohol Depend; 2022 Mar; 232():109319. PubMed ID: 35077955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reward processing in obesity, substance addiction and non-substance addiction.
    García-García I; Horstmann A; Jurado MA; Garolera M; Chaudhry SJ; Margulies DS; Villringer A; Neumann J
    Obes Rev; 2014 Nov; 15(11):853-69. PubMed ID: 25263466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.